Lingaraj Nayak

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• Safety and feasibility of outpatient induction with intensive monitoring in AML: pilot study and extension cohort
  Blood Global Hematology 2026 DOI: 10.1016/j.bglo.2026.100147
  +Save
• Multiple Myeloma in Young Adults—Insights From a Tertiary Care Cancer Centre in India
  eJHaem 2025 DOI: 10.1002/jha2.70187
  +Save
• Cyclophosphamide—A promising solution for refractory ICANS
  British Journal of Haematology 2025 DOI: 10.1111/bjh.70013
  +Save
• Skin and soft tissue manifestations in amyloid light-chain amyloidosis
  Indian Journal of Cancer 2025 DOI: 10.4103/ijc.ijc_1489_21
  +Save
• Impact of the COVID‐19 pandemic on treatment of patients with acute myeloid leukaemia in India
  British Journal of Haematology 2024 DOI: 10.1111/bjh.19750
  +Save
• Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL)
  Leukemia & Lymphoma 2023 DOI: 10.1080/10428194.2023.2244101
  +Save
• Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy
  British Journal of Haematology 2023 DOI: 10.1111/bjh.18659
  +Save
• Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia
  Blood Advances 2021 DOI: 10.1182/bloodadvances.2020003368
  +Save
• Lenalidomide as a Potent Inducer of Graft Versus Leukemia Effect in Patients with Hematologic Malignancies at High Risk of Relapse Post Allogeneic Stem Cell Transplant
  Indian Journal of Hematology and Blood Transfusion 2021 DOI: 10.1007/s12288-020-01362-0
  +Save
• Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol
  Blood Advances 2021 DOI: 10.1182/bloodadvances.2020003526
  +Save